CAMX Camurus AB (publ)

72.92USD739.50 SEK · STO-0.07%Mkt Cap: 4.34B USDP/E: 58.69

Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia. The company offers Buvidal, a buprenorphi…